ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
17.20
0.00 (0.00%)
Sep 3, 2025, 10:52 AM - Market open
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $4.10 billion as of September 3, 2025. Its market cap has increased by 0.22% in one year.
Market Cap
4.10B
Enterprise Value
4.10B
1-Year Change
0.22%
Ranking
Category
Stock Price
$17.20
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $4.10B, an increase of 8,076.19%. That is a compound annual growth rate of 44.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 4.12B | 1.60% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |